GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (XTER:AFX) » Definitions » Total Assets

Carl Zeiss Meditec AG (XTER:AFX) Total Assets : €2,920 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Carl Zeiss Meditec AG Total Assets?

Carl Zeiss Meditec AG's Total Assets for the quarter that ended in Mar. 2024 was €2,920 Mil.

Warning Sign:

If a company builds assets at 12.8% a year, faster than its revenue growth rate of 10.4% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Carl Zeiss Meditec AG's average Total Assets Growth Rate was 7.40% per year. During the past 3 years, the average Total Assets Growth Rate was 14.60% per year. During the past 5 years, the average Total Assets Growth Rate was 12.80% per year. During the past 10 years, the average Total Assets Growth Rate was 12.70% per year.

During the past 13 years, Carl Zeiss Meditec AG's highest 3-Year average Total Assets Growth Rate was 23.10%. The lowest was 2.00%. And the median was 14.15%.

Total Assets is connected with ROA %. Carl Zeiss Meditec AG's annualized ROA % for the quarter that ended in Mar. 2024 was 6.37%. Total Assets is also linked to Revenue through Asset Turnover. Carl Zeiss Meditec AG's Asset Turnover for the quarter that ended in Mar. 2024 was 0.16.


Carl Zeiss Meditec AG Total Assets Historical Data

The historical data trend for Carl Zeiss Meditec AG's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Total Assets Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,022.13 2,013.29 2,395.97 2,822.82 3,032.92

Carl Zeiss Meditec AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,732.13 - 3,032.92 - 2,920.19

Carl Zeiss Meditec AG Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Carl Zeiss Meditec AG's Total Assets for the fiscal year that ended in Sep. 2023 is calculated as

Total Assets=Total Equity (A: Sep. 2023 )+Total Liabilities (A: Sep. 2023 )
=2172.903+860.021
=3,033

Carl Zeiss Meditec AG's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=2107.273+812.915
=2,920

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carl Zeiss Meditec AG  (XTER:AFX) Total Assets Explanation

Total Assets is connected with ROA %.

Carl Zeiss Meditec AG's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=185.908/( (0+2920.188)/ 1 )
=185.908/2920.188
=6.37 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Carl Zeiss Meditec AG's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=472.125/( (0+2920.188)/ 1 )
=472.125/2920.188
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Carl Zeiss Meditec AG Total Assets Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (XTER:AFX) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG (XTER:AFX) Headlines

No Headlines